BioSpace News Archive

Press Releases

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

October 24, 2024
·
19 min read
Business

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

October 24, 2024
·
3 min read
Press Releases

Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic

October 24, 2024
·
3 min read
Press Releases

Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

October 24, 2024
·
1 min read
Press Releases

Allay Therapeutics Announces Expansion of Clinical and Scientific Advisory Boards to Support the Company’s Mission to Transform Post-Surgical Pain Management

October 24, 2024
·
12 min read
Press Releases

Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program

October 24, 2024
·
6 min read
Press Releases

ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

October 24, 2024
·
6 min read
Press Releases

Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease

October 24, 2024
·
9 min read
Press Releases

TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data

October 24, 2024
·
5 min read
Press Releases

CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology

October 24, 2024
·
5 min read